NCW visits TCS Nashik: What the fact-finding committee will examine and why its report matters beyond this case
Read More Pharma Industry News Aurobindo Pharma (NSE: AUROPHARMA) shares slide after FDA flags compliance gaps at Telangana unit Aurobindo Pharma shares fell after the US FDA flagged nine issues at a Telangana plant. Find out what it means for compliance, investors, and the stock outlook. byVenkateshFebruary 20, 2026